Pfizer Inc. (PFE) Q1 2015 Earnings Results

Pfizer Beats on EPS, Stock Down 0.32%

Pfizer's earnings report showed a slight beat on EPS, which indicates some positive momentum. However, the stock reacted negatively, declining by 0.32%. This could suggest that investors were looking for stronger revenue figures or more detailed guidance on future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.51	N/A	+1.19%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about the company's future prospects. They focused on ongoing projects and operational stability.

Management highlighted ongoing efforts in R&D to drive future growth.

They emphasized the importance of maintaining strong operational performance.

Pfizer Beats on EPS, Stock Down 0.32%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 0.32%

Key numbers

Management commentary